Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2017

View Archived Issues

Lin Bioscience licenses microtubule-targeting agent for brain cancer from University of Sydney

FDA accepts IND for phase I trials of TX-803 for colorectal cancer

Galapagos begins phase I study of cystic fibrosis potentiator GLPG-3067 under AbbVie collaboration

Fixed-dose combination tablets containing ertugliflozin show promise for type 2 diabetes

Preliminary results from malignant pleural mesothelioma cohort of KEYNOTE-028 study

Intec initiates phase I trial of AP-CBD/THC

FDA grants fast track designation to SHP-655 for hereditary thrombotic thrombocytopenic purpura

FDA clears Akashi to resume clinical development of HT-100

FDA grants orphan drug designation to avacopan for C3 glomerulopathy

Promising phase III data presented for alirocumab at ACC

Aveo initiates phase I/II trial of tivozanib and nivolumab in renal cell carcinoma

Achillion Pharmaceuticals patents complement factor D inhibitors

Eli Lilly and Company discloses new histone-lysine N-methyltransferase EZH2 inhibitors

Bayer Pharma discovers coagulation factor XIa and kallikrein inhibitors

Lilly initiates phase I trial of LY-3192767 in healthy subjects

Shenzhen Qingyaqirui Bio-Tech identifies new conjugates of memantine and arctigenin

Danish clearance for Oncology Venture's study of APO-010 in multiple myeloma

HitGen announces research collaboration with Merck & Co.

Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors

FDA grants orphan drug designation for Toleranzia's TOL-2

Cue Biopharma selects lead candidate Cue-101 targeting HPV-associated cancers

Aprea collaborates with Memorial Sloan Kettering to study p53 reactivation by APR-246

Sunesis submits responses to EMA for vosaroxin MAA review

Alexion seeks Japanese approval of Soliris in refractory AChR-positive generalized myasthenia gravis

Phase II seizure data on UX-007 in patients with glucose transporter type-1 deficiency syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...